Candidiasis
Learn about Candidiasis (Yeast Infection, Thrush, Moniliasis) diagnosis, including clinical documentation, medical coding, and healthcare best practices. Find information on symptoms, treatment, and ICD-10 codes related to Candida infections for accurate and efficient medical record keeping. This resource helps healthcare professionals stay up-to-date on Candidiasis diagnosis and management.
Fungal infection caused by Candida species, most commonly Candida albicans.
Itching, burning, white discharge (oral or vaginal), redness, soreness.
Skin folds, mouth, vagina, diaper area, weakened immune system.
ICD-10 Code Families
Complete code families applicable to B37.9
When to use each related code
| Description | When to use |
|---|---|
| Fungal infection caused by Candida species. | Use for infections of skin, mouth, genitals, or systemic candidiasis. Consider species if known. |
| Superficial fungal infection of the skin. | Use for dermatophytosis like ringworm, athlete's foot, jock itch. Specify body site if known. |
| Fungal infection of nails (onychomycosis). | Use for fungal nail infections. Specify affected nails (fingernails, toenails). |
Best-practice checklist
- ✓Document species (e.g., C. albicans)
- ✓Site of infection (e.g., oral, vaginal)
- ✓Signs/symptoms (e.g., white plaques, itching)
- ✓Confirm with lab test (e.g., KOH prep, culture)
- ✓Treatment plan (e.g., antifungals)
Common pitfalls to avoid
Coding candidiasis without specifying the affected site (e.g., oral, skin, vaginal) leads to inaccurate coding and claims.
Lack of proper clinical documentation to support the diagnosis of candidiasis can cause coding errors and compliance issues.
Using synonymous terms like "yeast infection" without clear documentation linking it to candidiasis can lead to coding ambiguity.
Best-practice tips
- 01ICD-10 B37 Candidiasis: Proper site, type coding.
- 02Candida albicans: Document species for microbiology.
- 03Yeast infection: Detail location, severity for CDI.
- 04Thrush: Differentiate oral, esophageal for accurate Rx.
- 05Moniliasis: Review risk factors (diabetes, antibiotics) in chart.
Step-by-step checklist
- 1
Confirm patient symptoms (itching, burning, discharge)
- 2
Visual exam: white plaques or redness
- 3
Microscopic exam (KOH prep) or culture
- 4
Consider patient risk factors (diabetes, antibiotics)
Ready-to-paste narrative
Patient presents with symptoms suggestive of candidiasis (yeast infection, thrush, moniliasis). Clinical findings include [Specify location of infection, e.g., oral thrush, vaginal yeast infection, cutaneous candidiasis, invasive candidiasis] characterized by [Describe specific signs and symptoms, e.g., white plaques on tongue and buccal mucosa, thick white vaginal discharge with pruritus, erythematous rash with satellite lesions]. Differential diagnosis includes [List relevant differential diagnoses, e.g., bacterial vaginosis, leukoplakia, contact dermatitis]. Diagnosis is based on [Specify diagnostic method, e.g., clinical presentation, microscopic examination with KOH prep revealing pseudohyphae and budding yeast cells, culture]. Patient's medical history includes [Note relevant medical history, e.g., diabetes mellitus, recent antibiotic use, immunosuppression]. Risk factors for candidiasis include [Document relevant risk factors, e.g., uncontrolled diabetes, antibiotic therapy, impaired immune system]. Treatment plan includes [Specify prescribed medication and dosage, e.g., fluconazole 150mg PO single dose, topical clotrimazole cream applied twice daily for 7 days]. Patient education provided regarding [List patient education topics, e.g., proper hygiene, medication administration, follow-up care]. ICD-10 code [Insert appropriate ICD-10 code, e.g., B37.9 for candidiasis, unspecified] is assigned. Follow-up appointment scheduled for [Date of follow-up] to assess treatment response and monitor for recurrent candidiasis. Plan to address any underlying conditions contributing to the infection.
Common questions and answers
What are the most effective diagnostic approaches for differentiating various types of candidiasis in clinical practice?+
Differentiating between cutaneous, mucosal, and invasive candidiasis requires a multifaceted approach. For cutaneous candidiasis, potassium hydroxide (KOH) microscopy can confirm the presence of yeast and hyphae. Mucosal infections, like oral thrush or vulvovaginal candidiasis, are often diagnosed based on clinical presentation and can be confirmed with microscopy or culture. Invasive candidiasis, which is a serious systemic infection, requires blood cultures, tissue biopsies, and potentially imaging studies like CT scans or MRI for accurate diagnosis and localization. Consider implementing a standardized protocol for candidiasis diagnosis in your practice to ensure accuracy and efficiency. Explore how different diagnostic tests contribute to the definitive identification of specific candidiasis types for optimal patient management.
How can I effectively manage recurrent vulvovaginal candidiasis in patients who present with persistent symptoms despite standard antifungal treatment?+
Recurrent vulvovaginal candidiasis (RVVC), defined as four or more episodes in a year, can be challenging to manage. Beyond standard antifungal treatments like fluconazole, consider exploring predisposing factors like uncontrolled diabetes, antibiotic use, or hormonal influences. Culture and sensitivity testing can identify non-albicans Candida species that may be resistant to conventional antifungals. Longer courses of treatment, maintenance therapy, and alternative antifungal agents may be necessary for RVVC. Learn more about the emerging research on probiotics and other complementary therapies for managing RVVC and improving patient outcomes. Consider implementing a comprehensive patient education strategy regarding hygiene practices, clothing choices, and sexual health to reduce recurrence rates.
What are the key considerations for managing oropharyngeal candidiasis in immunocompromised patients, including those with HIV/AIDS, undergoing chemotherapy, or receiving organ transplants?+
Oropharyngeal candidiasis (OPC) in immunocompromised patients presents unique challenges due to the increased risk of severe infection and esophageal involvement. Topical antifungal agents like nystatin or clotrimazole are often the first line of treatment. However, systemic antifungals like fluconazole or itraconazole may be necessary for refractory cases or in patients with esophageal candidiasis. Monitoring for drug interactions and adverse effects is crucial, especially in patients receiving multiple medications. Explore how prophylactic antifungal strategies can be implemented to prevent OPC in high-risk patients. Consider implementing regular oral examinations and prompt treatment of any suspicious lesions to prevent complications and improve quality of life for these vulnerable patients.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.